देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
Roxithromycin
Actavis Pty Ltd
Medicine Registered
ROXITHROMYCIN-GA _ROXITHROMYCIN FILM-COATED TABLETS_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Roxithromycin-GA. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risk of you taking this medicine against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT ROXITHROMYCIN-GA IS USED FOR This medicine is used to treat various infections caused by bacteria such as: acute pharyngitis (sore throat and discomfort when swallowing) tonsillitis sinusitis acute bronchitis (infection of the bronchi causing coughing) pneumonia (lung infection characterised by fever, malaise, headache) skin and soft tissue infections non gonococcal urethritis impetigo (bacterial infection causing sores on the skin). It contains the active ingredient roxithromycin. Roxithromycin belongs to a group of medicines called macrolides. It works by killing or stopping the growth of the bacteria that are causing the infection. However, Roxithromycin-GA does not have any effect on viral infections such as the flu. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is not addictive. This medicine is available only with a doctor’s prescription. BEFORE YOU TAKE ROXITHROMYCIN-GA _ _ _WHEN YOU MUST NOT TAKE IT _ DO NO पूरा दस्तावेज़ पढ़ें
120510 Roxithromycin-GA PI v5 Page 1 of 9 PRODUCT INFORMATION ROXITHROMYCIN-GA 150MG AND 300MG FILM-COATED TABLETS NAME OF THE MEDICINE Roxithromycin _Chemical name:_ Erythromycin-[O-[(2-methoxyethoxy)-methyl]oxime] CAS: 80214-83-1 Molecular formula_: _C 41 H 76 N 2 O 15 MW_:_ 837.1 DESCRIPTION It is a white crystalline powder. Roxithromycin-GA tablets also contain inactive ingredients: microcrystalline cellulose, povidone, croscarmellose sodium, silicon dioxide, lactose, hypromellose, titanium dioxide, magnesium stearate, macrogol 4000, poloxamer 188. PHARMACOLOGY Roxithromycin is a semisynthetic macrolide antibiotic. Microbiology At plasma concentrations achieved with the recommended therapeutic doses, roxithromycin has been demonstrated to have _in vitro_ and clinical activity against the following microorganisms: _Streptococcus pneumoniae, Strep. pyogenes, Mycoplasma pneumoniae, Moraxella _ _catarrhalis, Ureaplasma urealyticum_ and Chlamydia sp. Roxithromycin has been demonstrated to have clinical activity against the following microorganisms which are partially sensitive _in vitro_ to roxithromycin: _Haemophilus influenzae_ and _Staphylococcus aureus_, except methicillin resistant _Staph. _ _aureus_ (MRSA). 120510 Roxithromycin-GA PI v5 Page 2 of 9 The following strains of microorganisms are resistant: Multiresistant _Staph. aureus_, Enterobacteriaceae, Pseudomonas sp. and Acinetobacter sp. DISC SUSCEPTIBILITY TESTING _ _ Dilution or diffusion techniques – either quantitative (MIC) or breakpoint, should be used following a regularly updated, recognised and standard पूरा दस्तावेज़ पढ़ें